DISCOUNT-OPTIONSSCHEIN - FRESENIUS MEDICAL CARE Stock

Certificat

DE000HD4N3R2

Real-time BOERSE MUENCHEN 11:46:29 2024-07-04 EDT
2.34 EUR -0.85% Intraday chart for DISCOUNT-OPTIONSSCHEIN - FRESENIUS MEDICAL CARE
Current month+2.61%
1 month+24.87%
Date Price Change
24-07-04 2.34 -0.85%
24-07-03 2.36 -0.84%
24-07-02 2.38 +3.03%
24-07-01 2.31 +0.43%
24-06-28 2.3 -1.29%

Real-time BOERSE MUENCHEN

Last update July 04, 2024 at 11:46 am

More quotes

Static data

Product typeProduits Exotiques
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer UniCredit UniCredit
WKN HD4N3R
ISINDE000HD4N3R2
Date issued 2024-04-15
Strike 40
Maturity 2025-06-18 (349 Days)
Parity 1 : 1
Emission price 2.53
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.5
Lowest since issue 1.71
Spread 0.02
Spread %0.85%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.61 EUR
Average target price
39.97 EUR
Spread / Average Target
+12.25%
Consensus